73 related articles for article (PubMed ID: 16376884)
1. Characterisation of the interface between nucleophosmin (NPM) and p53: potential role in p53 stabilisation.
Lambert B; Buckle M
FEBS Lett; 2006 Jan; 580(1):345-50. PubMed ID: 16376884
[TBL] [Abstract][Full Text] [Related]
2. Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding.
Rippin TM; Freund SM; Veprintsev DB; Fersht AR
J Mol Biol; 2002 May; 319(2):351-8. PubMed ID: 12051912
[TBL] [Abstract][Full Text] [Related]
3. Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 Tat.
Gabizon R; Mor M; Rosenberg MM; Britan L; Hayouka Z; Kotler M; Shalev DE; Friedler A
Biopolymers; 2008; 90(2):105-16. PubMed ID: 18189286
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin regulates the stability and transcriptional activity of p53.
Colombo E; Marine JC; Danovi D; Falini B; Pelicci PG
Nat Cell Biol; 2002 Jul; 4(7):529-33. PubMed ID: 12080348
[TBL] [Abstract][Full Text] [Related]
5. TOE1 interacts with p53 to modulate its transactivation potential.
Sperandio S; Tardito S; Surzycki A; Latterich M; de Belle I
FEBS Lett; 2009 Jul; 583(13):2165-70. PubMed ID: 19508870
[TBL] [Abstract][Full Text] [Related]
6. The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.
Ma B; Pan Y; Gunasekaran K; Keskin O; Venkataraghavan RB; Levine AJ; Nussinov R
Phys Biol; 2005 Jun; 2(2):S56-66. PubMed ID: 16204849
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.
Xu H; Tai J; Ye H; Kang CB; Yoon HS
Biochem Biophys Res Commun; 2006 Mar; 341(4):938-44. PubMed ID: 16455050
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
9. Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domain.
Pivonková H; Brázdová M; Kaspárková J; Brabec V; Fojta M
Biochem Biophys Res Commun; 2006 Jan; 339(2):477-84. PubMed ID: 16300733
[TBL] [Abstract][Full Text] [Related]
10. Computational screening and design of S100B ligand to block S100B-p53 interaction.
Whitlow JL; Varughese JF; Zhou Z; Bartolotti LJ; Li Y
J Mol Graph Model; 2009; 27(8):969-77. PubMed ID: 19324580
[TBL] [Abstract][Full Text] [Related]
11. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
Ishimaru D; Ano Bom AP; Lima LM; Quesado PA; Oyama MF; de Moura Gallo CV; Cordeiro Y; Silva JL
Biochemistry; 2009 Jul; 48(26):6126-35. PubMed ID: 19505151
[TBL] [Abstract][Full Text] [Related]
12. Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.
Moulin S; Llanos S; Kim SH; Peters G
Oncogene; 2008 Apr; 27(17):2382-9. PubMed ID: 17968318
[TBL] [Abstract][Full Text] [Related]
13. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
Kulathila R; Vash B; Sage D; Cornell-Kennon S; Wright K; Koehn J; Stams T; Clark K; Price A
Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):58-66. PubMed ID: 19153467
[TBL] [Abstract][Full Text] [Related]
14. Calcium-dependent self-association of the C-type lectin domain of versican.
Ney A; Booms P; Epple G; Mörgelin M; Guo G; Kettelgerdes G; Gessner R; Robinson PN
Int J Biochem Cell Biol; 2006 Jan; 38(1):23-9. PubMed ID: 16159712
[TBL] [Abstract][Full Text] [Related]
15. Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis.
Zhang W; Navenot JM; Frilot NM; Fujii N; Peiper SC
Mol Pharmacol; 2007 Nov; 72(5):1310-21. PubMed ID: 17715399
[TBL] [Abstract][Full Text] [Related]
16. The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.
Okorokov AL; Sherman MB; Plisson C; Grinkevich V; Sigmundsson K; Selivanova G; Milner J; Orlova EV
EMBO J; 2006 Nov; 25(21):5191-200. PubMed ID: 17053786
[TBL] [Abstract][Full Text] [Related]
17. Unique complex between bacterial azurin and tumor-suppressor protein p53.
Apiyo D; Wittung-Stafshede P
Biochem Biophys Res Commun; 2005 Jul; 332(4):965-8. PubMed ID: 15913547
[TBL] [Abstract][Full Text] [Related]
18. Structure of the human p53 core domain in the absence of DNA.
Wang Y; Rosengarth A; Luecke H
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
[TBL] [Abstract][Full Text] [Related]
19. The C-terminus of p53: the more you learn the less you know.
Ahn J; Prives C
Nat Struct Biol; 2001 Sep; 8(9):730-2. PubMed ID: 11524665
[No Abstract] [Full Text] [Related]
20. RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells.
Jian Y; Gao Z; Sun J; Shen Q; Feng F; Jing Y; Yang C
Oncogene; 2009 Nov; 28(47):4201-11. PubMed ID: 19734942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
